Yellowstone Biosciences
Oxford
About Yellowstone Biosciences
Yellowstone seeks to identify a novel class of frequently expressed antigens that can be therapeutically targeted, With the potential to dramatically improve patient outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $20.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2024)
- Website: yellowstonebio.com
- Phone: [email protected]
Industries & Categories
Health Care, Therapeutics, Wellness
Canonical: https://fsome.com/organization/yellowstone-biosciences-37965 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.